Literature DB >> 1689463

Retinoblastoma in transgenic mice.

J J Windle1, D M Albert, J M O'Brien, D M Marcus, C M Disteche, R Bernards, P L Mellon.   

Abstract

Retinoblastoma, a malignancy of the eye occurring in young children, has been widely studied as a model for genetic predisposition to cancer. This disease is caused by mutations in both alleles of an anti-oncogene (the retinoblastoma gene, Rb) that inactivate or eliminate the Rb encoded protein, p105Rb (refs 1 and 2). Here we report that expression of a viral oncogene, the simian virus 40 T antigen, in the retina of transgenic mice produces heritable ocular tumours with histological, ultrastructural and immunohistochemical features identical to those of human retinoblastoma. Furthermore, we demonstrate a specific association between p105Rb and T antigen in mouse retinoblastoma tumour cells. Thus, the occurrence of these tumours is in vivo evidence for oncogenesis due to the ocular-specific expression of an Rb-binding oncoprotein that can functionally inactivate the Rb protein. As an animal model for heritable retinoblastoma, these mice should allow the study of the ontogeny, pathogenesis and treatment of this malignant disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1689463     DOI: 10.1038/343665a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  62 in total

1.  Loss of Id2 potentiates the tumorigenic effect of Rb inactivation in a mouse model of retinoblastoma.

Authors:  Solange Landreville; Duanduan Ma; Jun Wu; J William Harbour
Journal:  Curr Eye Res       Date:  2010-05       Impact factor: 2.424

2.  Effects of celecoxib in human retinoblastoma cell lines and in a transgenic murine model of retinoblastoma.

Authors:  C T Tong; S A Howard; H R Shah; K R Van Quill; E T Lin; H E Grossniklaus; J M O'Brien
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

Review 3.  Vitamin D: Implications for ocular disease and therapeutic potential.

Authors:  Rose Y Reins; Alison M McDermott
Journal:  Exp Eye Res       Date:  2015-02-25       Impact factor: 3.467

Review 4.  Mouse chromosome 4.

Authors:  R Blank; J Eppig; F T Fiedorek; W N Frankel; J M Friedman; K Huppi; I Jackson; B Mock
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

Review 5.  Transgenic regulation in laboratory animals.

Authors:  S Rusconi
Journal:  Experientia       Date:  1991-09-15

6.  Malignant melanoma in transgenic mice.

Authors:  M Bradl; A Klein-Szanto; S Porter; B Mintz
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

7.  The retinoblastoma protein physically associates with the human cdc2 kinase.

Authors:  Q J Hu; J A Lees; K J Buchkovich; E Harlow
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

8.  Rhabdomyosarcoma arising in transgenic mice harboring the beta-globin locus control region fused with simian virus 40 large T antigen gene.

Authors:  T Teitz; J C Chang; M Kitamura; T S Yen; Y W Kan
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

9.  Expression of the rasT24 oncogene in the ciliary body pigment epithelium and retinal pigment epithelium results in hyperplasia, adenoma, and adenocarcinoma.

Authors:  P Chévez-Barrios; D L Schaffner; R Barrios; P A Overbeek; R M Lebovitz; M W Lieberman
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

10.  Impact of tumor-associated macrophages in LH(BETA)T(AG) mice on retinal tumor progression: relation to macrophage subtype.

Authors:  Yolanda Piña; Hinda Boutrid; Timothy G Murray; Martine J Jager; Colleen M Cebulla; Amy Schefler; Long V Ly; Armando Alegret; Magda Celdran; William Feuer; Maria-Elena Jockovich
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-06       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.